17056/34347US=33 / Dor/Paliativo
Hardy JR, Jackson II KC. Codeine. In: Davis MP, Glare P, Hardy JR, Quigley C, editors. Opioids in cancer pain: science, evaluation, and management, na interdisciplinary approach. 2nd ed. Oxford: Oxford Univeristy Press, 2009. p. 81-7. ISBN 978-0-19-923664-0.

CODEINA; FARMACOCINETICA; FARMACODINAMICA

17057/34347US=33 / Dor/Paliativo
Davis MP. Hydrocodone. In: Davis MP, Glare P, Hardy JR, Quigley C, editors. Opioids in cancer pain: science, evaluation, and management, na interdisciplinary approach. 2nd ed. Oxford: Oxford Univeristy Press, 2009. p. 89-98. ISBN 978-0-19-923664-0.

HIDROCODONA; FARMACODINAMICA; FARMACOCINETICA; VIAS DE ADMINISTRACAO; INTERACOES MEDICAMENTOSAS; TOXIDADE DROGAS

17058/34347US=8 / Laboratório
Pardanani A, Tefferi A. Mast cells and systemic mastocytosis. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2009. p. 1187-98. ISBN 978-0-443-06715-0.

MASTOCITOS; MASTOCITOSE SISTEMICA; MASTOCITOSE. PATOGENESE; MASTOCITOSE. MANIFESTACOES CLINICAS; MASTOCITOSE. DIAGNOSTICO; MASTOCITOSE. TRATAMENTO

17059/34347US=33 / Dor/Paliativo
Glare P. Dextropropoxyphene. In: Davis MP, Glare P, Hardy JR, Quigley C, editors. Opioids in cancer pain: science, evaluation, and management, na interdisciplinary approach. 2nd ed. Oxford: Oxford Univeristy Press, 2009. p. 119-25. ISBN 978-0-19-923664-0.

DEXTROPROPOXIFENO; FARMACOLOGIA; FARMACODINAMICA; DOSAGEM EM POPULACOES ESPECIAIS; DOR ONCOLOGICA. BASEADA EM EVIDENCIAS

17060/34347US=33 / Dor/Paliativo
Glare P. Morphine. In: Davis MP, Glare P, Hardy JR, Quigley C, editors. Opioids in cancer pain: science, evaluation, and management, na interdisciplinary approach. 2nd ed. Oxford: Oxford Univeristy Press, 2009. p. 127-53. ISBN 978-0-19-923664-0.

MORFINA; FARMACOLOGIA; FARMACODINAMICA; FARMACOCINETICA; FARMACOLOGIA DA MORFINA GLUCORONIDOS; INTERACOES DRUNG; TOXICIDADE; DOSAGEM EM POPULACOES ESPECIAIS; CANCER. BASEADA EM EVIDENCIAS

17061/34347US=33 / Dor/Paliativo
Glare P, Davis MP. Oxycodone. In: Davis MP, Glare P, Hardy JR, Quigley C, editors. Opioids in cancer pain: science, evaluation, and management, na interdisciplinary approach. 2nd ed. Oxford: Oxford Univeristy Press, 2009. p. 155-73. ISBN 978-0-19-923664-0.

OXICODONA; FARMACODINAMICA; FARMACOCINETICA; OXICODONA PARA A DOR ONCOLOGICA

17062/34347US=33 / Dor/Paliativo
Hall A, Hardy JR. The lipophilic opioids: fentanyl, alfentanil, sufentanil, and remifentanil. In: Davis MP, Glare P, Hardy JR, Quigley C, editors. Opioids in cancer pain: science, evaluation, and management, na interdisciplinary approach. 2nd ed. Oxford: Oxford Univeristy Press, 2009. p. 175-92. ISBN 978-0-19-923664-0.

OPIOIDES LIPOFILICOS; FENTANIL; ALFENTANIL; SUFENTANIL; REMIFENTANIL; ADMINISTRACAO TRANSDERMICA; INFUSAO SUBCUTANEA; ADMINISTRACAO TRANSMUCOSA; ADMINISTRACAO INTRANASAL

17063/34347US=33 / Dor/Paliativo
Davis MP. Buprenorphine. In: Davis MP, Glare P, Hardy JR, Quigley C, editors. Opioids in cancer pain: science, evaluation, and management, na interdisciplinary approach. 2nd ed. Oxford: Oxford Univeristy Press, 2009. p. 193-209. ISBN 978-0-19-923664-0.

BUPRENORFINA; FARMACODINAMICA; FARMACOCINETICA; INTERACOES MEDICAMENTOSAS; TOXICIDADE; DOR DO CANCER. BASE DE EVIDENCIAS; ROTACAO DE OPIOIDES A BUPRENORFINA

17064/34347US=8 / Laboratório
Smith FO, Loh ML. Myelodysplastic and myloproliferative syndromes in children. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2009. p. 1199-206. ISBN 978-0-443-06715-0.

SINDROME MIELODISPLASICA; SINDROME MIELOPROLIFERATIVA; LEUCEMIA MIELOMONOCITICA JUVENIL; SINDROME DE DOWN; TROMBOCITEMIA ESSENCIAL; MIELOFIBROSE IDIOPATICA; POLICITEMIA VERA

17065/34347US=8 / Laboratório
Lenz G, Staudt LM. Pathobiology of non-Hodgkin lymphoma. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2009. p. 1207-20. ISBN 978-0-443-06715-0.

LINFOMA NAO HODGKIN; LINFOMA DIFUSO DE GRANDES CELULAS B; QUIMIOTERAPIA; EXPRESSAO DO GENE; LINFOMA DE BURKITT; LINFOMA FOLICULAR; LINFOMA DE CELULAS DO MANTO

17066/34347US=33 / Dor/Paliativo
Davis MP, Quigley C. Methadone. In: Davis MP, Glare P, Hardy JR, Quigley C, editors. Opioids in cancer pain: science, evaluation, and management, na interdisciplinary approach. 2nd ed. Oxford: Oxford Univeristy Press, 2009. p. 211-43. ISBN 978-0-19-923664-0.

METADONA; FARMACODINAMICA; FARMACOCINETICA; MONITORIZACAO TERAPEUTICA; TOXICIDADE; METADONA EM CANCER AVANCADO

17067/34347US=8 / Laboratório
Pileri SA, Falini B, Agostinelli C, Stein H. Pathobiology of Hodgkin lymphoma. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2009. p. 1221-38. ISBN 978-0-443-06715-0.

LINFOMA HODGKIN; LINFOMA DE HODGKIN NODULAR LINFOCITO PREDOMINANTE; LINFOMA HODGKIN CLASSICO; VIRUS EPSTEIN-BARR; ESCLEROSE NODULAR; CELULARIDADE MISTA; LINFOCITOS EMPOBRECIDOS

17068/34347US=33 / Dor/Paliativo
Quigley C, Glare P. Hydromorphone. In: Davis MP, Glare P, Hardy JR, Quigley C, editors. Opioids in cancer pain: science, evaluation, and management, na interdisciplinary approach. 2nd ed. Oxford: Oxford Univeristy Press, 2009. p. 245-52. ISBN 978-0-19-923664-0.

HIDROMORFONA; FARMACOLOGIA; FARMACODINAMICA; FARMACOCINETICA; DOR NO CANCER. BASE DE EVIDENCIAS; HIDROMORFONA CONTRA MORFINA; HIDROMORFONA CONTRA MORFINA; HIDROMORFONA CONTRA OXICODONA; HIDROMORFONA COMO CONTROLE ATIVO

17069/34347US=33 / Dor/Paliativo
Davis MP. Levorphanol. In: Davis MP, Glare P, Hardy JR, Quigley C, editors. Opioids in cancer pain: science, evaluation, and management, na interdisciplinary approach. 2nd ed. Oxford: Oxford Univeristy Press, 2009. p. 253-61. ISBN 978-0-19-923664-0.

LEVORFANOL; FARMACODINAMICA; FARMACOCINETICA; DOR ONCOLOGICA. BASE DE EVIDENCIAS

17070/34347US=8 / Laboratório
Diehl V, Klimm B, Re D. Hodgkin lymphoma: clinical manifestations, staging, and therapy. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2009. p. 1239-64. ISBN 978-0-443-06715-0.

LINFOMA DE HODGKIN. MANIFESTACOES CLINICAS; LINFOMA DE HODGKIN. ESTADIAMENTO; LINFOMA DE HODGKIN. TRATAMENTO; VIRUS EPSTEIN-BARR

17071/34347US=33 / Dor/Paliativo
Hardy JR, Quigley C. Diamorphine. In: Davis MP, Glare P, Hardy JR, Quigley C, editors. Opioids in cancer pain: science, evaluation, and management, na interdisciplinary approach. 2nd ed. Oxford: Oxford Univeristy Press, 2009. p. 263-8. ISBN 978-0-19-923664-0.

DIAMORFINA; PROPRIEDADES FISICO-QUIMICAS; FARMACOCINETICA; FARMACODINAMICA

17072/34347US=8 / Laboratório
Jaffe ES, Pittaluga S. The pathologic basis for the classification of non-Hodgkin lymphomas. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2009. p. 1265-80. ISBN 978-0-443-06715-0.

LINFOMAS NAO-HODGKIN; LEUCEMIA/LINFOMA LINFOBLASTICO B; LEUCEMIA/LINFOMA LINFOBLASTICO T; LEUCEMIA LINFOCITICA CRONICA; LEUCEMIA LINFOCITICA AGUDA; LINFOMA LINFOPLASMOCITICO; LINFOMA DE CELULAS DO MANTO; LINFOMA FOLICULAR; TECIDO LINFOIDE ASSOCIADO A MUCOSA (MALT); LINFOMA NODAL DE CELULAS B NA ZONA MARGINAL; LINFOMA DE ZONA MARGINAL ESPLENICO; LINFOMA DIFUSO DE GRANDES CELULAS B; LINFOMA MEDIASTINAL (TIMICO) DE CELULAS B GRANDES; LINFOMA DE EFUSAO PRIMARIA; LINFOMA PLASMABLASTICO; LINFOMA DE BURKITT; LINFOMA DE CELULAS T; LINFOMA DE CELULAS NK; LINFOMA DE CELULAS T ANGIOIMUNOBLASTICA; LINFOMA DE CELULAS T PERIFERICA; LINFOMA ANAPLASICO DE GRANDES CELULAS; SINDROME DE SEZARY; MICOSE FUNGOIDE

17073/34347US=33 / Dor/Paliativo
Glare P. Oxymorphone. In: Davis MP, Glare P, Hardy JR, Quigley C, editors. Opioids in cancer pain: science, evaluation, and management, na interdisciplinary approach. 2nd ed. Oxford: Oxford Univeristy Press, 2009. p. 269-74. ISBN 978-0-19-923664-0.

OXIMORFONA; FARMACOLOGIA; FARMACODINAMICA; FARMACOCINETICA; DOR NO CANCER. BASE DE EVIDENCIAS

17074/34347US=8 / Laboratório
Gribben JG. Clinical manifestations, staging, and treatment of indolent non-Hodgkin lymphoma. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2009. p. 1281-92. ISBN 978-0-443-06715-0.

LINFOMA NAO HODGKIN. EPIDEMIOLOGIA; LINFOMA NAO HODGKIN. APRESENTACAO CLINICA; LINFOMA NAO HODGKIN. DIAGNOSTICO; LINFOMA NAO HODGKIN. ESTADIAMENTO; LINFOMA FOLICULAR; LINFOMA DA ZONA MARGINAL; LINFOMA LINFOPLASMOCITICO; MACROGLOBULINEMIA DE WALDENSTROM; LINFOMA LINFOCITICO DE CELULAS PEQUENAS; LINFOMA DE CELULAS DO MANTO; LINFOMA NAO HODGKIN. TRATAMENTO

17075/34347US=33 / Dor/Paliativo
Glare P. Choice of opioids and the WHO ladder. In: Davis MP, Glare P, Hardy JR, Quigley C, editors. Opioids in cancer pain: science, evaluation, and management, na interdisciplinary approach. 2nd ed. Oxford: Oxford Univeristy Press, 2009. p. 275-85. ISBN 978-0-19-923664-0.

OPIOIDES EA ESCADA OMS; OPIOIDES FORTES CONTRA OPIOIDES FRACOS; EVIDENCIE PARA A ESCADA; APLICABILIDADE DA ESCADA; MANEJO DA DOR

Primeira | Anterior | Próxima | Última